Spyros Papapetropoulos

Entity
Individual
Business address
C/O Adamas Pharmaceuticals, Inc., 1900 Powell St., Suite 1000, 94608 Emeryville, CA
Signature Ownership
/s/ Spyros Papapetropoulos
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Spyros Papapetropoulos has filed 20 SEC EDGAR filings since 11/24/2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing Sep 2, 2025 Aug 27, 2025 001-41157
4 Open Document Open Filing Jun 5, 2025 Jun 4, 2025 001-36357
4/A Open Document Open Filing May 19, 2025 Apr 16, 2025 001-41157
4 Open Document Open Filing OWNERSHIP DOCUMENT Apr 18, 2025 Apr 16, 2025 001-41157
3 Open Document Open Filing Jul 8, 2024 Jul 1, 2024 001-41157
4 Open Document Open Filing Jun 7, 2024 Jun 5, 2024 001-36357
4 Open Document Open Filing May 12, 2023 May 10, 2023 001-36357
4 Open Document Open Filing Nov 28, 2022 Nov 22, 2022 001-36357
4 Open Document Open Filing FORM 4 SUBMISSION Nov 22, 2022 Nov 18, 2022 001-41200
4 Open Document Open Filing Jun 10, 2022 Jun 8, 2022 001-36357
4 Open Document Open Filing FORM 4 SUBMISSION May 4, 2022 May 3, 2022 001-41200
4 Open Document Open Filing Apr 12, 2022 Apr 11, 2022 001-36357
3 Open Document Open Filing Apr 12, 2022 Apr 11, 2022 001-36357
4 Open Document Open Filing FORM 4 SUBMISSION Mar 3, 2022 Mar 1, 2022 001-41200
3 Open Document Open Filing FORM 3 SUBMISSION Jan 6, 2022 Jan 6, 2022 001-41200
4 Open Document Open Filing FORM 4 Nov 24, 2021 Nov 24, 2021 001-36399
4 Open Document Open Filing FORM 4 Jun 4, 2021 Jun 2, 2021 001-36399
4 Open Document Open Filing FORM 4 SUBMISSION Mar 15, 2021 Mar 11, 2021 001-36399
4 Open Document Open Filing FORM 4 SUBMISSION Nov 24, 2020 Nov 22, 2020 001-36399
3 Open Document Open Filing FORM 3 SUBMISSION Nov 24, 2020 Nov 22, 2020 001-36399